oseltamivir phosphate
NDC 70436-225, oseltamivir phosphate, capsule, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-225
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218009
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OSELTAMIVIR PHOSPHATE75 mg/1
Pharmacologic classes
Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-225-47 | 70436022547 | 1 BLISTER PACK in 1 CARTON (70436-225-47) / 10 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/613c8c4d-e647-4a4b-ac9b-c39aaa781ace
Use it
Look up 70436-225 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.